Azman, A. S., F. J. Luquero, A. Rodrigues, P. P. Palma, R. F. Grais, C. N. Banga, B. T. Grenfell, and J. Lessler. 2012. Urban cholera transmission hotspots and their implications for reactive vaccination: evidence from Bissau city, Guinea bissau. PLoS Negl Trop Dis 6:e1901.
Lopman, B. A., V. E. Pitzer, R. Sarkar, B. Gladstone, M. Patel, J. Glasser, M. Gambhir, C. Atchison, B. T. Grenfell, W. J. Edmunds, G. Kang, and U. D. Parashar. 2012. Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PLoS One 7:e41720.
Metcalf, C. J., J. Lessler, P. Klepac, A. Morice, B. T. Grenfell, and O. N. Bjornstad. 2012. Structured models of infectious disease: inference with discrete data. Theor Popul Biol 82:275-282.
Bharti, N., H. Broutin, R. F. Grais, M. J. Ferrari, A. Djibo, A. J. Tatem, and B. T. Grenfell. 2012. Spatial dynamics of meningococcal meningitis in Niger: observed patterns in comparison with measles. Epidemiol Infect 140:1356-1365.
Arinaminpathy, N., J. S. Lavine, and B. T. Grenfell. 2012. Self-boosting vaccines and their implications for herd immunity. Proc Natl Acad Sci U S A 109:20154-20159.
Cutts, F. T., C. J. Metcalf, J. Lessler, and B. T. Grenfell. 2012. Rubella vaccination: must not be business as usual. Lancet 380(9838):217-218.
Saenz, R. A., S. C. Essen, S. M. Brookes, M. Iqbal, J. L. Wood, B. T. Grenfell, J. W. McCauley, I. H. Brown, and J. R. Gog. 2012. Quantifying transmission of highly pathogenic and low pathogenicity H7N1 avian influenza in turkeys. PLoS One 7:e45059.
Lin, W. H., R. D. Kouyos, R. J. Adams, B. T. Grenfell, and D. E. Griffin. 2012. Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics. Proc Natl Acad Sci U S A 109:14989- 14994.
Klepac, P., O. N. Bjornstad, C. J. Metcalf, and B. T. Grenfell. 2012. Optimizing reactive responses to outbreaks of immunizing infections: balancing case management and vaccination. PLoS One 7:e41428.
Lessler, J., C. J. Metcalf, and B. T. Grenfell. 2012. Measurement of vaccine-derived immunity: how do we use all the data? Expert Rev Vaccines 11:747-749.